Article Information
History
- February 17, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- T. Yanes1,#,*,
- C. Wallingford1,#,
- MA. Young2,3,
- A.M. McInerney-Leo1,
- A. Willis2,3,
- L. McKnight2,
- B. Terrill2,
- S. McInerny4,
- L. Forrest4,
- L. Cicciarelli4,
- R. Williams5,6,
- H. Keane4 and
- PA James4,7
- 1Frazer Institute, The University of Queensland, Dermatology Research Centre, Brisbane QLD 4102
- 2Clinical Translational and Engagement Platform, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia
- 3School of Clinical Medicine, UNSW Medicine & Health, St Vincent’s Healthcare Clinical Campus, Faculty of Medicine and Health, UNSW Sydney, NSW, Australia
- 4Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre and the Royal Melbourne Hospital, Melbourne VIC 3000, Australia
- 5School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Kensington, NSW, Australia
- 6Hereditary Cancer Centre, Prince of Wales Hospital, Randwick, 2031, Australia
- 7Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne VIC 3052, Australia
- ↵*Corresponding authors: Tatiane Yanes, email: t.yanes{at}uq.edu.au
↵# Authors contributed equally.
Posted February 17, 2023.
Development and evaluation of a novel educational program for providers on the use of polygenic risk scores
